Citrix Systems, Inc. (NASDAQ:CTXS) announced that Gartner, Inc., has positioned the company in the leaders quadrant of the 2014 Magic Quadrant for Enterprise Mobility Management (EMM) Suites1 report. The report evaluates the Citrix XenMobile® solution, a comprehensive EMM solution that delivers mobile device management (MDM), mobile application management (MAM), mobile content management and enterprise-grade productivity apps on premises or in the cloud. Citrix Systems, Inc. (NASDAQ:CTXS) stock opened today at $62.82 and is currently trading at $63.97. The stock showed a positive weekly performance of 2.21%.
Receptos Inc (NASDAQ:RCPT) announced that the Phase 2 portion of the RADIANCE trial of its selective S1P1 receptor modulator, RPC1063, in relapsing multiple sclerosis (RMS) met the primary endpoint, reduction in MRI brain lesion activity. The overall safety profile of RPC1063 was consistent with the results of prior trials, and continues to support the differentiation of the drug candidate against other oral agents for treatment of RMS on the market or in clinical development. Receptos Inc (NASDAQ:RCPT) stock opened at $39.75, in current trading session and currently is at $39.37, by gaining 34.93%. The 52 week range of $15.21 – $55.00. Company’s market capitalization is $877.90 billion.
Following a management dinner, UBS said Zynga Inc (NASDAQ:ZNGA) remains focused on executing on 2014 guidance, NaturalMotion integration, maximizing lifetime franchise value, and increasing operating leverage. The analyst said its core investment thesis for improved bookings growth and margin leverage remains intact and reiterates its Buy rating and $6 price target. Zynga Inc (NASDAQ:ZNGA) stock is open at $3.06 and currently trading at $3.16. The EPS of the stock is -0.12. Company’s market capitalization is $2.81 billion.
B/E Aerospace Inc (NASDAQ:BEAV) on Tuesday said it plans to split its operations into two independent, publicly traded companies, as the aircraft interiors maker continues its strategic review. B/E Aerospace Inc (NASDAQ:BEAV) stock opened the session at $95.50, and now is at $94.21. The 52 week range of the BEAV stock remained $60.47 – $101.13 and the day range was $93.23 – $95.80.
On May 30, 2014, Avanir Pharmaceuticals Inc (NASDAQ:AVNR) announced that data related to the prevalence and treatment of pseudobulbar affect (PBA), a distressing neurological condition characterized by uncontrollable laughing or crying, will be presented at the following conferences in June. Avanir Pharmaceuticals Inc (NASDAQ:AVNR) stock opened at $5.58, in current trading session and currently is at $5.40, by gaining 1.12%. The 52 week range of $2.62 – $6.00. Company’s market capitalization is $860.95 billion.